When the Box Was Opened...

A few days ago a man who has a large apple orchard, which did not yield the usual crop this year, said to me: I do not know what our children will do for apples to carry to school in the lunches this year. Heretofore they have been sure of the apple a day

Help for Laboring Teachers...

How well do I remember how much it meant to me when I was a young teacher to find a book on methods of teaching some subject over which I was laboring

Omicron Nu

Twice a year a few junior and Senior women find tucked under their doors, notes which have been left there in the early morning hours while they were still asleep. Such a note means an invitation to become a member of the home economics honor organization, Omicron Nu. The invitation brings a thrill because it means a recognition of work well done and serves as a spur to increased effort. Gamma Chapter, which was installed in 1913, has initiated 317 women into active membership. The national comprises 23 chapters

The Iowa Homemaker vol.6, no.2

Table of Contents Dedication, page 1 Invitation to The House by Maybelle A. Payton, page 2 Dedication of the Home Economics Hall, page 3 Home Economics of Tomorrow by Anna E. Richardson, page 5 And Now Comes the Fulfillment by Joanna M. Hansen, page 6 Pioneering in Home Economics by Josephine McMullen, page 8 With the Iowa State Home Economics Association, page 6 The Past Decade in Home Economics at I. S. C., page 9 The Dean MacKay Auditorium by Thirza Hull, page 10 Division of Home Economics by Marcia E. Turner, page 11 ‘Twas Team Work That Did It, page 12 Omicron Nu by Cora B. Miller, page 13 Girls’ 4-H Clubs, page 14 With the Iowa State Home Economics Association, page 1

The Iowa Homemaker vol.11, no.8

House Not for Sale… By Joanne M. Hansen, page 1 Home Management Mothers… By Helen Bishop, page 2 “Tell Me a Poem”… By Lorraine Sandstrom, page 3 When the Box Was Opened… By Cora B. Miller, page 4 Just Serve Yourself… By Ida M. Shilling, page 4 Modernizing Marriage… By Ethel Cessna Morgan, page 5 Girls 4-H Clubs By Clara Austin, page 6 Alumnae Echoes… By Anafred Stephenson, page 8 Editorial, page 9 Inside Information By Helen Jewell and Betty Martin, page 1

Considering sex as a biological variable in preclinical research

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/154390/1/fsb2fj201600781r.pd

CMB-S4 Science Book, First Edition

This book lays out the scientific goals to be addressed by the next-generation ground-based cosmic microwave background experiment, CMB-S4, envisioned to consist of dedicated telescopes at the South Pole, the high Chilean Atacama plateau and possibly a northern hemisphere site, all equipped with new superconducting cameras. CMB-S4 will dramatically advance cosmological studies by crossing critical thresholds in the search for the B-mode polarization signature of primordial gravitational waves, in the determination of the number and masses of the neutrinos, in the search for evidence of new light relics, in constraining the nature of dark energy, and in testing general relativity on large scales

Design and Feasibility of an Intervention to Support Cancer Genetic Counselees in Informing their At-Risk Relatives

Cancer genetic counselees receive individualized information regarding heightened risks and medical recommendations which is also relevant for their at-risk relatives. Unfortunately, counselees often insufficiently inform these relatives. We designed an intervention aimed at improving counselees' knowledge regarding which at-risk relatives to inform and what information to disclose, their motivation to disclose, and their self-efficacy. The intervention, offered by telephone by trained psychosocial workers, is based on the principles of Motivational Interviewing. Phase 1 of the intervention covers agenda setting, exploration, and evaluation, and phase 2 includes information provision, enhancing motivation and self-efficacy, and brainstorming for solutions to disseminate information within the family. Fidelity and acceptability of the intervention were assessed using recordings of intervention sessions and by counselee self-report. A total of 144 counselees participated. Psychosocial workers (n = 5) delivered the intervention largely as intended. Counselees highly appreciated the content of the intervention and the psychosocial workers who delivered the intervention. In the sessions, psychosocial workers provided additional and/or corrective information, and brainstorming for solutions was performed in 70 %. These results indicate that this intervention is feasible and warrants testing in clinical practice. For this, a randomized controlled trial is currently in progress to test the intervention's efficacy

Enzalutamide in European and North American men participating in the AFFIRM trial

Objective To explore any differences in efficacy and safety outcomes between European (EU) (n = 684) and North American (NA) (n = 395) patients in the AFFIRM trial (NCT00974311).Patients and Methods Phase III, double-blind, placebo-controlled, multinational AFFIRM trial in men with metastatic castration-resistant prostate cancer (mCRPC) after docetaxel. Participants were randomly assigned in a 2:1 ratio to receive oral enzalutamide 160 mg/day or placebo. The primary end point was overall survival (OS) in a post hoc analysis.Results Enzalutamide significantly improved OS compared with placebo in both EU and NA patients. The median OS in EU patients was longer than NA patients in both treatment groups. However, the relative treatment effect, expressed as hazard ratio and 95% confidence interval, was similar in both regions: 0.64 (0.50, 0.82) for EU and 0.63 (0.47, 0.83) for NA. Significant improvements in other end points further confirmed the benefit of enzalutamide over placebo in patients from both regions. The tolerability profile of enzalutamide was comparable between EU and NA patients, with fatigue and nausea the most common adverse events. Four EU patients (4/461 enzalutamide-treated, 0.87%) and one NA patient (1/263 enzalutamide-treated, 0.38%) had seizures. The difference in median OS was related in part to the timing of development of mCRPC and baseline demographics on study entry.Conclusion This post hoc exploratory analysis of the AFFIRM trial showed a consistent OS benefit for enzalutamide in men with mCRPC who had previously progressed on docetaxel in both NA- and EU-treated patients, although the median OS was higher in EU relative to NA patients. Efficacy benefits were consistent across end points, with a comparable safety profile in both regions. © 2014 The Authors. BJU International published by John Wiley & Sons Ltd on behalf of BJU International